Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Economic Development topic

No spam. Unsubscribe anytime.

Board approves incentive package to bring Organogenesis to Smithfield site

Board of Licensing for Chemical Dependency Professional · November 1, 2024
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The board approved tax-credit and job-incentive assistance for Organogenesis Holding Inc., contingent on the company signing a Smithfield lease and reaching tax-stabilization terms with the town. The package includes $10 million in rebuild tax credits and an estimated $3.2 million in Qualified Jobs credits.

The board voted to approve an incentives package to attract Organogenesis Holding Inc. to a former Alexion site in Smithfield, conditioned on the company finalizing a lease and the town completing a tax-stabilization agreement.

Jeff Miller, the meeting presenter, described Organogenesis as "a developer of wound therapies" that is considering a Smithfield lease and said the board's package includes "$10,000,000 worth of rebuild tax credits and an estimated $3,200,000 of Qualified Jobs tax credits." Neil Steinberg, introduced by a board member as heading the state's life-sciences effort, said the state's $5,000,000 life-sciences award is contingent on this board's approval and the company reaching terms with the town.

The board discussed timing and contingencies: staff said Organogenesis hopes to sign a lease in mid-November, and that certain tax-credit payments only begin after a certificate of occupancy and are disbursed over five years. A motion to approve carried by voice vote with no recorded opposition; the board recorded the approval as contingent on the lease and related town agreements.